Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism. Audrey Deprince , Nathalie Hennuyer , Sander Kooijman , Amanda C M Pronk , Eric Baugé , Viktor Lienard , An Verrijken , Eveline Dirinck , Luisa Vonghia , Eloïse Woitrain , Niels J Kloosterhuis , Eléonore Marez , Pauline Jacquemain , Justina C Wolters , Fanny Lalloyer , Delphine Eberlé , Sandrine Quemener , Emmanuelle Vallez , Anne Tailleux , Mostafa Kouach , Jean-Francois Goossens , Violeta Raverdy , Bruno Derudas , Jan Albert Kuivenhoven , Mikaël Croyal , Bart van de Sluis , Sven Francque , François Pattou , Patrick C N Rensen , Bart Staels , Joel T Haas Hepatology (Baltimore, Md.)（2023）
摘要
These data reveal a previously undescribed role for ApoF in the control of plasma and hepatic lipoprotein metabolism by favoring VLDL-TG secretion and hepatic lipoprotein remnant particle clearance.
更多 查看译文
AI 理解论文
溯源树
样例
